维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="Garon EB"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Pernbrolizumab for the treat- ment of non-small-cell lung cancer显示文摘	Garon EB Rizvi NA Hui R	2015	N EnglJ Med2015，372，21：	1
2	Quantum dot labeling and tracking of human leukemic,bone marrow and cord blood cell 显示文摘	Garon EB Marcu L Luong Q	2007	Leuk Res2007，31，5：	1
3	Pembrolizumab for the treatment of non-small-cell lung cancer 显示文摘	Garon EB Rizvi NA Hui R	2015	N Engl J Med2015，372，21：	1
4	Point break: A randomized phase m study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage m B or 1V nonsquamous non-small-cell lung cancer 显示文摘	Patel JD Socinski MA Garon EB	2013	J Ctin Onco12013，31，34：	1
5	Uncertainty and psychological adjustment in patients with lung cancer 显示文摘	Kurita K Garon EB Stanton AL	2013	Psychooncology2013，22，6：	1
6	Ramucirumab plus docetaxel versus placebo plus docetaxel for second-linetreatment of state IV-non-small-cell lung cancer after disease progression on platinum-based therapy(REVEL): a multicenter, double-blind, randomized phase 3 trial显示文摘	Garon EB Cluleanu TE Arrieta O	2014	Lancet2014，384，9944：	1
7	A randomized, double-blind, phase III study of Docetaxel and Ramucirumab versus Docetaxel and placebo in the treatment of stage IV non-small-cell lung cancer after disease progression after 1 previous platinum-based therapy (REVEL): treatment rationale and study design 显示文摘	Garon EB Cao D Alexandris E	2012	Clin Lung Cancer2012，13，6：	1
8	A phase Ⅱa study of ABT-263 in patients with relapsed small-cell lung cancer (SCLC)显示文摘	Rudin CM Oliveira MR Garon EB	2010	J Clin Oncol2010，28，15：	1
9	Pembrolizumab for the treatment of non-small-cell lung cancer 显示文摘	Garon EB Rizvi NA Hui R	2015	N Engl J Med2015，372，21：	1
10	Pembrolizumab for the treatment of non-small-cell lung cancer 显示文摘	Garon EB Rizvi NA Hui R	2015	N Engl J Med2015，372，21：	1
11	Pembrolizumab for the treatment of non-small-cell lung cancer显示文摘	Garon EB Rizvi NA Hui R	2015	N Engl J Med2015，372，21：	1
12	Pembrolizumab for the treat- ment of non-small-cell lung cancer显示文摘	Garon EB Rizvi NA Hui R	2015	N Engl J Med2015，372，21：	1
13	Pembrolizumab for the treatment of non-small-cell lung cancer 显示文摘	Garon EB Rizvi N A Hui R	2016	N Eng J Med2016，16，：	1
14	PointBreak: a random-ized phase ]]I study of pemetrexed plus carboplatin and bevacizum- ab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by mainte- nance bevacizumab in patients with stage IH B or 1V nonsqua- mous non-small-cell lung cancer显示文摘	Patel JD Socinski MA Garon EB	2013	J Clin Oncol2013，31，34：	1
15	Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC) 显示文摘	Garon EB Leighl NB Rizvi NA	2014	J Clin Oneol2014，32，15：	1
16	Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-sman cell lung cancer (NSCLC) 显示文摘	Rizvi NA Garon EB Patnaik A	2014	J Clin Oncol2014，32，5：	1
17	The HsPg0 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth显示文摘	Garon EB Finn RS Hamidi H	2013	Mol Cancer Ther2013，12，6：	1
18	MK-3475 monother- apy for previously treated non-small cell lung cancer ( NSCLC ) : Preliminary safety and clinical activity 显示文摘	GARON EB ANIBALMANOUKIAN	2014	Clin Cancer Res2014，20，：	1
19	Antitumor activity of pembrolizumab (Pembro; MK-3475) and correlation with programmed death ligand 1 (PD-L1) expression in a pooled analysis of patients (pts) with advanced non-small cell lung carcinoma (NSCLC)显示文摘	Garon EB Rizvi N Patnaik A	2014	ESMO2014，43，：	1
20	PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevaeizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage RIB or IV nonsquamous non-small-cell lung cancer显示文摘	PATEL JD SOCINSKI MA GARON EB et 01	2013	J Clin Oncol2013，31，34：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示